• Celligenics

Celligenics Signs MOU With Series A Investor Best World International (April 2021)

Celligenics is pleased to announce that we have signed a Memorandum of Understanding (MOU) with our Series A investor, Best World International (BWI), and we look forward to the next stage of our strategic partnership, as we move closer towards the development and launch of our next generation of stem cell-based healthcare and wellness products.



70 views0 comments